ANVS logo

Annovis Bio (ANVS)

Profile

Full Name

Annovis Bio, Inc.

Ticker Symbol

ANVS

Exchange

NYSE

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 29, 2020

Indexes

Not included

Website

http://www.annovisbio.com

Employees

8

Key Details

Price

$1.69(-0.59%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.31(+62.92% YoY)

PE ratio

-

Next earnings date

Aug 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.69
    ANVS price is $1.69

    30-Day Relative Volume

    1.75
    ANVS 30-day relative volume is 1.75

    Price Performance

    Price Most recent change

    -0.59%
    ANVS price was down -0.59% on May 14, 2025

    Price YTD change

    -66.4%
    ANVS price is down -66.4% since January 1st

    Price 1-year change

    -79.78%
    ANVS price is down -79.78% year-on-year

    Price 3-year change

    -82.06%
    ANVS price is down -82.06% over the past 3 years

    Price Range

    Price All-time high

    $132.00
    ANVS price is currently -98.72% below its historical high of $132.00

    Price 3-year low

    $1.11
    ANVS price is currently +52.25% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $32.93M
    ANVS market capitalization is $32.93 million

    Market cap 3-year change

    -57.18%
    ANVS market capitalization is down -57.18% over the past 3 years

    Market cap All-time high

    $978.76M
    ANVS market capitalization is currently -96.64% below its historical high of $978.76 million

    Market cap sector rank

    31.54%
    ANVS market capitalization is higher than 31.54% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +74.43%
    ANVS shares outstanding is up +74.43% year-on-year

    Shares Outstanding 3-Year Change

    +138.69%
    ANVS shares outstanding is up +138.69% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.46
    ANVS beta is 1.46

    200-day SMA

    $5.38
    ANVS price is currently -68.60% below its 200-day simple moving average

    50-day SMA

    $1.56
    ANVS price is currently +8.19% above its 50-day simple moving average

    RSI

    56.78
    ANVS 14-day relative strength index is 56.78

    Volume

    1.75
    ANVS 30-day relative volume is 1.75

    ATR

    $0.22
    ANVS average true range is $0.22

    10-day Historical Volatility

    90.24%
    ANVS 10-day historical volatility is 90.24%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ANVS annual revenue value is unknown

    Revenue Analysts estimate

    -
    ANVS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    ANVS annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ANVS annual revenue is unknown

    EPS

    EPS

    -$2.31
    ANVS annual earnings per share is -$2.31

    EPS Analysts estimate

    -$0.78
    ANVS annual earnings per share is currently +196.15% higher than the consensus analysts' forecast

    EPS 1-year change

    +62.92%
    ANVS annual earnings per share is up +62.92% year-on-year

    EPS Sector rank

    35.88%
    ANVS annual earnings per share is higher than 35.88% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ANVS annual gross profit value is unknown

    Gross margin

    -
    ANVS annual gross profit margin value is unknown

    Operating profit

    -$26.69M
    ANVS annual operating income is -$26.69 million

    Operating margin

    -
    ANVS annual operating profit margin value is unknown

    Net income

    -$24.59M
    ANVS annual net profit is -$24.59 million

    Net margin

    -
    ANVS annual net profit margin value is unknown

    Expenses

    Total expenses

    $26.69M
    ANVS annual total expenses is $26.69 million

    Operating expenses

    $26.69M
    ANVS annual total operating expenses is $26.69 million

    Cost of goods sold

    -
    ANVS annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $6.70M
    ANVS annual SGA is $6.70 million

    Depreciation and amortization

    -
    ANVS annual depreciation & amortization value is unknown

    Interest expense

    -
    ANVS annual interest expense value is unknown

    Income tax

    -
    ANVS annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$26.69M
    ANVS annual earnings before interest & taxes is -$26.69 million

    EBITDA

    -$26.69M
    ANVS annual EBITDA is -$26.69 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $13.93M
    ANVS annual total assets is $13.93 million

    Non current assets

    $0.00
    ANVS annual long term assets is $0.00

    Current assets

    $13.93M
    ANVS annual total current assets is $13.93 million

    Cash and cash equivalents

    $10.55M
    ANVS annual cash & cash equivalents is $10.55 million

    Accounts receivable

    -
    ANVS annual accounts receivable value is unknown

    Inventory

    -
    ANVS annual inventory value is unknown

    Liabilities

    Total liabilities

    $4.62M
    ANVS annual total liabilities is $4.62 million

    Long term liabilities

    $737.00K
    ANVS annual total long term liabilities is $737.00 thousand

    Current liabilities

    $3.88M
    ANVS annual total current liabilities is $3.88 million

    Accounts payable

    $2.31M
    ANVS annual accounts payable is $2.31 million

    Debt

    Total debt

    $0.00
    ANVS annual total debt is $0.00

    Total debt 1-year change

    0%
    ANVS {parameterFullLabel} has remained unchanged year-on-year

    Long term debt

    -
    ANVS annual long term debt value is unknown

    Short term debt

    -
    ANVS annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $9.31M
    ANVS annual stockholders equity is $9.31 million

    Book value

    $9.31M
    ANVS annual book value is $9.31 million

    Retained earnings

    -$134.85M
    ANVS annual retained earnings is -$134.85 million

    Working capital

    $10.04M
    ANVS annual working capital is $10.04 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$21.89M
    ANVS annual cash flow from operations is -$21.89 million

    Cash from operations 1-year change

    +45.22%
    ANVS annual cash flow from operations is up +45.22% year-on-year

    Cash from investing

    -
    ANVS annual cash flow from investing activities value is unknown

    Cash from investing 1-year change

    -
    ANVS annual cash flow from investing activities 1-year change is unknown

    Cash from financing

    $26.69M
    ANVS annual cash flow from financing activities is $26.69 million

    Cash from financing 1-year change

    +53.89%
    ANVS annual cash flow from financing activities is up +53.89% year-on-year

    CAPEX

    CAPEX

    -
    ANVS annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ANVS annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$21.89M
    ANVS annual free cash flow is -$21.89 million

    Free cash flow 1-year change

    +45.22%
    ANVS annual free cash flow is up +45.22% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ANVS annual gross profit margin value is unknown

    Operating margin

    -
    ANVS annual operating profit margin value is unknown

    Net margin

    -
    ANVS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -176.58%
    ANVS annual return on assets is -176.58%

    ROE

    -264.20%
    ANVS annual return on equity is -264.20%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ANVS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ANVS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.54
    ANVS price to book ratio is 3.54

    PB ratio Sector rank

    74.82%
    ANVS price to book ratio is higher than 74.82% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ANVS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ANVS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $22.38M
    ANVS enterprise value is $22.38 million

    Enterprise value Sector rank

    31.13%
    ANVS enterprise value is higher than 31.13% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.84
    ANVS EV/EBITDA is -0.84

    EV/EBITDA Sector rank

    46.62%
    ANVS EV/EBITDA is higher than 46.62% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.59
    ANVS annual current ratio is 3.59

    Quick ratio

    -
    ANVS annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ANVS annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ANVS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ANVS piotroski f-score value is unknown

    Altman Z-Score

    -
    ANVS altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Feb 10, 25 D. Boral Capital
    Hold
    Nov 11, 24 HC Wainwright & Co.
    Buy
    Nov 11, 24 D. Boral Capital
    Buy
    Oct 25, 24 Maxim Group
    Buy
    Aug 15, 24 HC Wainwright & Co.
    Buy
    Aug 15, 24 EF Hutton
    Buy
    Aug 13, 24 EF Hutton
    Buy
    Jul 17, 24 HC Wainwright & Co.
    Buy
    Jul 11, 24 HC Wainwright & Co.
    Buy
    Jul 2, 24 Rodman & Renshaw
    Buy

    Institutional Ownership

    Screeners with ANVS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Earnings this week
    • What is the ticker symbol for Annovis Bio?
    • Does Annovis Bio pay dividends?
    • What sector is Annovis Bio in?
    • What industry is Annovis Bio in?
    • What country is Annovis Bio based in?
    • When did Annovis Bio go public?
    • Is Annovis Bio in the S&P 500?
    • Is Annovis Bio in the NASDAQ 100?
    • Is Annovis Bio in the Dow Jones?
    • When was Annovis Bio's last earnings report?
    • When does Annovis Bio report earnings?
    • Should I buy Annovis Bio stock now?

    What is the ticker symbol for Annovis Bio?

    The ticker symbol for Annovis Bio is NYSE:ANVS

    Does Annovis Bio pay dividends?

    No, Annovis Bio does not pay dividends

    What sector is Annovis Bio in?

    Annovis Bio is in the Healthcare sector

    What industry is Annovis Bio in?

    Annovis Bio is in the Biotechnology industry

    What country is Annovis Bio based in?

    Annovis Bio is headquartered in United States

    When did Annovis Bio go public?

    Annovis Bio's initial public offering (IPO) was on January 29, 2020

    Is Annovis Bio in the S&P 500?

    No, Annovis Bio is not included in the S&P 500 index

    Is Annovis Bio in the NASDAQ 100?

    No, Annovis Bio is not included in the NASDAQ 100 index

    Is Annovis Bio in the Dow Jones?

    No, Annovis Bio is not included in the Dow Jones index

    When was Annovis Bio's last earnings report?

    Annovis Bio's most recent earnings report was on May 13, 2025

    When does Annovis Bio report earnings?

    The next expected earnings date for Annovis Bio is Aug 14, 2025

    Should I buy Annovis Bio stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page